Pharmacoeconomic review report. Ozenoxacin 1% cream (Ozanex), (Ferrer internacional, S.A.) : indication : the topical treatment of impetigo in patients aged two months and older.

Pharmacoeconomic review report. indication : the topical treatment of impetigo in patients aged two months and older. Ozenoxacin 1% cream (Ozanex), (Ferrer internacional, S.A.) :

Ozenoxacin 1% cream is a topical non-fluorinated quinolone antibiotic indicated for the treatment of impetigo in patients aged two months or older. The recommended use for ozenoxacin is the application of a thin layer of cream to affected areas twice daily for five days. It is available in 10 g tube...

Full description

Saved in:

Bibliographic Details
Online Access:	Full text
Format:	Electronic eBook
Language:	English
Published:	Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 2018
Series:	Common drug review clinical review report.
Subjects:	Impetigo > drug therapy. Infant. Child. Quinolones > therapeutic use. Quinolones > economics. Cost-Benefit Analysis. Children. Family members. Canada. Tables.

CADTH Canadian Drug Expert Committee recommendation. Ozenoxacin 1% cream (Ozanex -- Ferrer Internacional, S.A.) : indication: the topical treatment of impetigo in patients aged two...

Version: Final.

Published 2018

Full text

Electronic eBook

Clinical review report. Ozenoxacin 1% cream (Ozanex) (Ferrer internacional, S.A.) : indication : the topical treatment of impetigo in patients aged two months and older.